# Title

 Food and Drugs. PART 106â€”INFANT FORMULA REQUIREMENTS PERTAINING TO CURRENT GOOD MANUFACTURING PRACTICE, QUALITY CONTROL PROCEDURES, QUALITY FACTORS, RECORDS AND REPORTS, AND NOTIFICATIONS


# ID

 CFR-2018-title21-vol2.Pt. 106


# Structured Analysis Summary

| Type        | Values                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|:------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Constraints | ['not to exceed', 'greater', 'exceeds', 'more than', 'no later than', 'before', 'after', 'prior to', 'minimum', 'at least', 'exceed', 'within', 'no less than', 'later than', 'no more than']                                                                                                                                                                                                                                                                           |
| Duration    | ['1.0 month', '4.0 month', '11.0 week', '2.0 week', '3.0 year', '36.0 month', '15.0 week', '24.0 month', '15.0 day', '1.0 year', '90.0 day', '4.0 year', '12.0 month', '4.0 week', '24.0 hour']                                                                                                                                                                                                                                                                         |
| Condition   | ['subject to', 'until', 'where', 'not subject to', 'when', 'provided that', 'unless', 'if']                                                                                                                                                                                                                                                                                                                                                                             |
| Entities    | ['Failure', 'Eligible', 'Such', 'Bethesda, MD', 'Physical', 'Food', 'Drizd, C.L', 'Length', 'Agriculture', 'Infant', 'Verification', 'U.S', 'American Journal', 'Atlanta, GA', 'Roche, and W.M', 'Head', 'Quality', 'Establish', 'United States', 'Correspondence', 'Indicator', 'Agency', 'Shall', 'Boiler', 'Medicine', 'Reed, A.F', 'Certain', 'Nutrition, Labeling', 'Traceability', 'Good', 'Audit', 'McLean, VA', 'North', 'New', 'Nutrient', 'E', 'Enforcement'] |
| Date        | ['2015-11-12', '2009-11-01', '2014-12-08', '2004-11-21', '2013-04-08', '1979-03-01']                                                                                                                                                                                                                                                                                                                                                                                    |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                                                  |
|:--------------|:-------------------------------------------------------------------------------------------------------------------------|
| before        | stage means the point in the manufacturing process, before distribution of an infant formula, at which the               |
| more than     | Infant means a person not  more than  12 months of age.                                                                  |
| before        | ingredients at any point in the manufacturing process before  packaging.                                                 |
| within        | intended to have uniform composition, character, and quality, within specified limits, and is produced according to a    |
| within        | manufacture that has uniform composition, character, and quality, within  specified limits.                              |
| minimum       | regulations set forth in this subpart define the minimum current good manufacturing practices that are to be             |
| before        | soap and running water at a suitable temperature before starting work, after each absence from the work                  |
| after         | water at a suitable temperature before starting work, after each absence from the work station, and at                   |
| after         | for use in, or as, infant formula; and after                                                                             |
| after         | release for use in infant formula production or after  release of the final product.                                     |
| after         | release for use in infant formula production or after  release of the final product.                                     |
| prior to      | defluoridated to a level as low as possible prior to  use.                                                               |
| before        | known reference standard at the time of or before first use and thereafter at routine intervals, as                      |
| after         | time of or before first use and there after at routine intervals, as specified in writing by                             |
| not to exceed | for a final infant formula at a temperature not to exceed 45 &#176;F (7.2 &#176;C) for a defined period                  |
| within        | reflect, on a continuing basis, the true temperature, within the compartment; (C) Equipping the cold storage compartment |
| prior to      | manufacturer shall ensure that each system is validated prior to the release for distribution of any infant formula      |
| prior to      | is modified is revalidated following the modification and prior to the release for distribution of any infant formula    |
| within        | A substance that is not a food additive within the meaning of section 201(s) of the Federal                              |
| before        | formula, including the filtering of the intake air before heating, to prevent microbial and other contamination; (3)     |
| before        | powdered infant formula at the final product stage, before distribution, to ensure that each production aggregate meets  |
| exceeds       | powdered infant formula that contains any microorganism that exceeds the M value listed for that microorganism in        |
| no later than | product, and a &#8220;use by&#8221; date that is no later than the &#8220;use by&#8221; date of the container exhibiting |
| after         | the manufacturer's specifications; (2) During the manufacturing process, after the addition of the premix, or at the     |
| before        | premix, or at the final product stage but before distribution, each production aggregate of infant formula shall         |
| at least      | aggregate of infant formula shall be tested for at least one indicator nutrient for each of the nutrient                 |
| before        | (3) At the final product stage,  before distribution of an infant formula, each production aggregate                     |
| before        | manufacturing process or at the final product stage, before distribution, each production aggregate shall be tested for  |
| after         | shall repeat such testing every 4 months there after  throughout the shelf life of the product.                          |
| minimum       | regulations set forth in this subpart define the minimum requirements for quality factors for infant formulas: (a)       |
| no less than  | study of the infant formula that: (1) Is no less than 15 weeks in duration, enrolling infants no more                    |
| no more than  | less than 15 weeks in duration, enrolling infants no more than 2 weeks old at time of entry into                         |
| at least      | the beginning and end of the study, and at least four additional measurements made at intermediate time points           |
| within        | with three of the six total measurements made within the first 4 weeks of the study and                                  |
| more than     | or (iii) The manufacturer markets a formulation in more than one form (e.g., liquid and powdered forms) and              |
| prior to      | conducted on a formula and the results evaluated prior to the initiation of a growth monitoring study of                 |
| no less than  | source of nutrition; (B) The growth study is no less than 4 months in duration, enrolling infants no more                |
| no more than  | less than 4 months in duration, enrolling infants no more than 1 month old at time of entry into                         |
| at least      | growth study, at 2 weeks, at 4 weeks, at least monthly thereafter, and at the conclusion of the                          |
| after         | weeks, at 4 weeks, at least monthly there after , and at the conclusion of the study;                                    |
| later than    | manufacturer of an eligible infant formula may, not later than November 12, 2015, submit a petition to the               |
| within        | would cause an infant formula to be adulterated within the meaning of section 402(a)(2)(C) of the Federal                |
| exceed        | the premix supplier, including tests conducted when nutrients exceed  their expiration date or shelf life (retest date). |
| exceed        | identify the nutrient levels present when nutrient premixes exceed  their expiration date or shelf life (retest date).   |
| more than     | occurred; (ii) For a manufacturing facility that has more than  one set of equipment or                                  |
| more than     | occurred; (ii) For a manufacturing facility that has more than  one set of equipment or                                  |
| minimum       | At a  minimum , such records shall specify the instrument or                                                             |
| within        | formula and an infant's death, the manufacturer shall, within 15 days of receiving such information, conduct an          |
| within        | in the complaint file, they must be available within 24 hours when requested by a Food and                               |
| within        | all records required by this section are available within 24 hours of request for inspection at that                     |
| within        | can be provided with access to such records within  24 hours.                                                            |
| after         | appropriate regulations, shall be retained for 1 year after the expiration of the shelf life of the                      |
| greater       | years from the date of manufacture, whichever is greater .                                                               |
| before        | (HFS-850), 5001 Campus Dr., College Park, MD 20740-3835. before                                                          |
| at least      | Drug Administration at the address given in &#167;&#8201;106.110(a). at least                                            |
| before        | (a) At least 90 days  before a new infant formula is introduced or delivered                                             |
| before        | manufacturer shall not market the new infant formula before the date that is 90 days after the                           |
| after         | formula before the date that is 90 days after  the filing date.                                                          |
| before        | and Drug Administration will so notify the manufacturer before  the expiration of the 90th day.                          |
| before        | Calculations of the statistical power of the study before  study initiation and at study completion.                     |
| after         | (a) A manufacturer shall,  after the first production and before the introduction into                                   |
| before        | A manufacturer shall, after the first production and before the introduction into interstate commerce of a new           |
| before        | Cosmetic Act (21 U.S.C. 350a(a)), the manufacturer shall, before the first processing of such formula, make a            |
| before        | What steps will be taken to ensure that, before the formula is introduced into interstate commerce, the                  |
| after         | Drug Administration's emergency number, 1-866-300-4374 shall be used. after                                              |


## Duration

| Duration   | Context                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:-----------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 12.0 month | Infant means a person not more than 12 months of age.                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 4.0 year   | (3) A manufacturer shall conduct the tests required by paragraph (f)(2) of this section with sufficient frequency to ensure that the water meets the EPA's Primary Drinking Water Regulations but shall not conduct these tests less frequently than annually for chemical contaminants, every 4 years for radiological contaminants, and weekly for bacteriological contaminants.                                                                                           |
| 4.0 month  | The manufacturer shall repeat such testing every 4 months thereafter throughout the shelf life of the product.                                                                                                                                                                                                                                                                                                                                                               |
| 15.0 week  | (b) A manufacturer of an infant formula that is not an eligible infant formula shall demonstrate that a formula supports normal physical growth in infants when fed as a sole source of nutrition by conducting, in accordance with good clinical practice, an adequate and well-controlled growth monitoring study of the infant formula that:                                                                                                                              |
|            |               (1) Is no less than 15 weeks in duration, enrolling infants no more than 2 weeks old at time of entry into the study;                                                                                                                                                                                                                                                                                                                                          |
|            |               (2) Includes the collection and maintenance of data on formula intake and anthropometric measures of physical growth, including body weight, recumbent length, head circumference, average daily weight increment, and average daily recumbent length increment;                                                                                                                                                                                               |
|            |               (3) Includes anthropometric measurements made at the beginning and end of the study, and at least four additional measurements made at intermediate time points with three of the six total measurements made within the first 4 weeks of the study and three measurements made at approximately 4-week intervals over the remaining 11 weeks of the study;                                                                                                    |
|            |               (4) Compares the anthropometric data for the test group to a concurrent control group or groups at each time point and compares the anthropometric data for each infant (body weight for age, body length for age, head circumference for age, and weight for length) in the test group and the control group to the 2009 CDC growth charts, which are incorporated by reference at &#167;&#8201;106.160; and                                                  |
|            |               (5) Compares the data on formula intake of the test group with a concurrent control group or groups and a scientifically appropriate reference.                                                                                                                                                                                                                                                                                                                |
| 2.0 week   | (b) A manufacturer of an infant formula that is not an eligible infant formula shall demonstrate that a formula supports normal physical growth in infants when fed as a sole source of nutrition by conducting, in accordance with good clinical practice, an adequate and well-controlled growth monitoring study of the infant formula that:                                                                                                                              |
|            |               (1) Is no less than 15 weeks in duration, enrolling infants no more than 2 weeks old at time of entry into the study;                                                                                                                                                                                                                                                                                                                                          |
|            |               (2) Includes the collection and maintenance of data on formula intake and anthropometric measures of physical growth, including body weight, recumbent length, head circumference, average daily weight increment, and average daily recumbent length increment;                                                                                                                                                                                               |
|            |               (3) Includes anthropometric measurements made at the beginning and end of the study, and at least four additional measurements made at intermediate time points with three of the six total measurements made within the first 4 weeks of the study and three measurements made at approximately 4-week intervals over the remaining 11 weeks of the study;                                                                                                    |
|            |               (4) Compares the anthropometric data for the test group to a concurrent control group or groups at each time point and compares the anthropometric data for each infant (body weight for age, body length for age, head circumference for age, and weight for length) in the test group and the control group to the 2009 CDC growth charts, which are incorporated by reference at &#167;&#8201;106.160; and                                                  |
|            |               (5) Compares the data on formula intake of the test group with a concurrent control group or groups and a scientifically appropriate reference.                                                                                                                                                                                                                                                                                                                |
| 4.0 week   | (b) A manufacturer of an infant formula that is not an eligible infant formula shall demonstrate that a formula supports normal physical growth in infants when fed as a sole source of nutrition by conducting, in accordance with good clinical practice, an adequate and well-controlled growth monitoring study of the infant formula that:                                                                                                                              |
|            |               (1) Is no less than 15 weeks in duration, enrolling infants no more than 2 weeks old at time of entry into the study;                                                                                                                                                                                                                                                                                                                                          |
|            |               (2) Includes the collection and maintenance of data on formula intake and anthropometric measures of physical growth, including body weight, recumbent length, head circumference, average daily weight increment, and average daily recumbent length increment;                                                                                                                                                                                               |
|            |               (3) Includes anthropometric measurements made at the beginning and end of the study, and at least four additional measurements made at intermediate time points with three of the six total measurements made within the first 4 weeks of the study and three measurements made at approximately 4-week intervals over the remaining 11 weeks of the study;                                                                                                    |
|            |               (4) Compares the anthropometric data for the test group to a concurrent control group or groups at each time point and compares the anthropometric data for each infant (body weight for age, body length for age, head circumference for age, and weight for length) in the test group and the control group to the 2009 CDC growth charts, which are incorporated by reference at &#167;&#8201;106.160; and                                                  |
|            |               (5) Compares the data on formula intake of the test group with a concurrent control group or groups and a scientifically appropriate reference.                                                                                                                                                                                                                                                                                                                |
| 4.0 week   | (b) A manufacturer of an infant formula that is not an eligible infant formula shall demonstrate that a formula supports normal physical growth in infants when fed as a sole source of nutrition by conducting, in accordance with good clinical practice, an adequate and well-controlled growth monitoring study of the infant formula that:                                                                                                                              |
|            |               (1) Is no less than 15 weeks in duration, enrolling infants no more than 2 weeks old at time of entry into the study;                                                                                                                                                                                                                                                                                                                                          |
|            |               (2) Includes the collection and maintenance of data on formula intake and anthropometric measures of physical growth, including body weight, recumbent length, head circumference, average daily weight increment, and average daily recumbent length increment;                                                                                                                                                                                               |
|            |               (3) Includes anthropometric measurements made at the beginning and end of the study, and at least four additional measurements made at intermediate time points with three of the six total measurements made within the first 4 weeks of the study and three measurements made at approximately 4-week intervals over the remaining 11 weeks of the study;                                                                                                    |
|            |               (4) Compares the anthropometric data for the test group to a concurrent control group or groups at each time point and compares the anthropometric data for each infant (body weight for age, body length for age, head circumference for age, and weight for length) in the test group and the control group to the 2009 CDC growth charts, which are incorporated by reference at &#167;&#8201;106.160; and                                                  |
|            |               (5) Compares the data on formula intake of the test group with a concurrent control group or groups and a scientifically appropriate reference.                                                                                                                                                                                                                                                                                                                |
| 11.0 week  | (b) A manufacturer of an infant formula that is not an eligible infant formula shall demonstrate that a formula supports normal physical growth in infants when fed as a sole source of nutrition by conducting, in accordance with good clinical practice, an adequate and well-controlled growth monitoring study of the infant formula that:                                                                                                                              |
|            |               (1) Is no less than 15 weeks in duration, enrolling infants no more than 2 weeks old at time of entry into the study;                                                                                                                                                                                                                                                                                                                                          |
|            |               (2) Includes the collection and maintenance of data on formula intake and anthropometric measures of physical growth, including body weight, recumbent length, head circumference, average daily weight increment, and average daily recumbent length increment;                                                                                                                                                                                               |
|            |               (3) Includes anthropometric measurements made at the beginning and end of the study, and at least four additional measurements made at intermediate time points with three of the six total measurements made within the first 4 weeks of the study and three measurements made at approximately 4-week intervals over the remaining 11 weeks of the study;                                                                                                    |
|            |               (4) Compares the anthropometric data for the test group to a concurrent control group or groups at each time point and compares the anthropometric data for each infant (body weight for age, body length for age, head circumference for age, and weight for length) in the test group and the control group to the 2009 CDC growth charts, which are incorporated by reference at &#167;&#8201;106.160; and                                                  |
|            |               (5) Compares the data on formula intake of the test group with a concurrent control group or groups and a scientifically appropriate reference.                                                                                                                                                                                                                                                                                                                |
| 4.0 month  | (i) The following provisions for requirements for quality factors apply only to an &#8220;eligible infant formula&#8221; as defined in &#167;&#8201;106.3:                                                                                                                                                                                                                                                                                                                   |
|            |               (1) An eligible infant formula that fulfills one or more of the following criteria meets the quality factor of normal physical growth:                                                                                                                                                                                                                                                                                                                         |
|            |               (i) The scientific evidence on such infant formula meets the requirements of paragraph (b) of this section that apply to infant formula that is not an eligible infant formula;                                                                                                                                                                                                                                                                                |
|            |               (ii) The scientific evidence on such infant formula meets the following provisions:                                                                                                                                                                                                                                                                                                                                                                            |
|            |               (A) The evidence is an adequate and well-controlled growth study, conducted in accordance with good clinical practice, to determine whether an infant formula supports normal physical growth in infants when the formula is fed as the sole source of nutrition;                                                                                                                                                                                              |
|            |               (B) The growth study is no less than 4 months in duration, enrolling infants no more than 1 month old at time of entry into the study;                                                                                                                                                                                                                                                                                                                         |
|            |               (C) The growth study collects from the study subjects data on anthropometric measures of physical growth, including body weight, recumbent length, head circumference, and average daily weight increment, and plots the data on the following charts from &#8220;Physical Growth: National Center for Health Statistics Percentiles&#8221; for body weight, body length, and head circumference, which are incorporated by reference at &#167;&#8201;106.160: |
|            |               (1) Figure 1.                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 1.0 month  | (i) The following provisions for requirements for quality factors apply only to an &#8220;eligible infant formula&#8221; as defined in &#167;&#8201;106.3:                                                                                                                                                                                                                                                                                                                   |
|            |               (1) An eligible infant formula that fulfills one or more of the following criteria meets the quality factor of normal physical growth:                                                                                                                                                                                                                                                                                                                         |
|            |               (i) The scientific evidence on such infant formula meets the requirements of paragraph (b) of this section that apply to infant formula that is not an eligible infant formula;                                                                                                                                                                                                                                                                                |
|            |               (ii) The scientific evidence on such infant formula meets the following provisions:                                                                                                                                                                                                                                                                                                                                                                            |
|            |               (A) The evidence is an adequate and well-controlled growth study, conducted in accordance with good clinical practice, to determine whether an infant formula supports normal physical growth in infants when the formula is fed as the sole source of nutrition;                                                                                                                                                                                              |
|            |               (B) The growth study is no less than 4 months in duration, enrolling infants no more than 1 month old at time of entry into the study;                                                                                                                                                                                                                                                                                                                         |
|            |               (C) The growth study collects from the study subjects data on anthropometric measures of physical growth, including body weight, recumbent length, head circumference, and average daily weight increment, and plots the data on the following charts from &#8220;Physical Growth: National Center for Health Statistics Percentiles&#8221; for body weight, body length, and head circumference, which are incorporated by reference at &#167;&#8201;106.160: |
|            |               (1) Figure 1.                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 36.0 month | Length by age percentiles for girls aged birth-36 months (p.                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 36.0 month | Length by age percentiles for boys aged birth-36 months (p.                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 36.0 month | Weight by age percentiles for girls aged birth-36 months (p.                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 36.0 month | Weight by age percentiles for boys aged birth-36 months (p.                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 36.0 month | Head circumference by age percentiles for girls aged birth-36 months (p.                                                                                                                                                                                                                                                                                                                                                                                                     |
| 36.0 month | Weight by length percentiles for girls aged birth-36 months (p.                                                                                                                                                                                                                                                                                                                                                                                                              |
| 36.0 month | Head circumference by age percentiles for boys aged birth-36 months (p.                                                                                                                                                                                                                                                                                                                                                                                                      |
| 36.0 month | Weight by length percentiles for boys aged birth-36 months (p.                                                                                                                                                                                                                                                                                                                                                                                                               |
| 2.0 week   | (D) The growth study collects anthropometric measurements at the beginning of the growth study, at 2 weeks, at 4 weeks, at least monthly thereafter, and at the conclusion of the study; or                                                                                                                                                                                                                                                                                  |
| 4.0 week   | (D) The growth study collects anthropometric measurements at the beginning of the growth study, at 2 weeks, at 4 weeks, at least monthly thereafter, and at the conclusion of the study; or                                                                                                                                                                                                                                                                                  |
| 15.0 day   | (3) When there is a reasonable possibility of a causal relationship between the consumption of an infant formula and an infant's death, the manufacturer shall, within 15 days of receiving such information, conduct an investigation and notify the Agency as required in &#167;&#8201;106.150.                                                                                                                                                                            |
| 24.0 hour  | When copies of such records are not maintained in the complaint file, they must be available within 24 hours when requested by a Food and Drug Administration official.                                                                                                                                                                                                                                                                                                      |
| 24.0 hour  | When the manufacturer wishes to maintain all consumer complaints for the entire firm at one location other than at the facility where an infant formula was manufactured, processed, or packed, the manufacturer may do so as long as all records required by this section are available within 24 hours of request for inspection at that facility.                                                                                                                         |
| 24.0 hour  | (m) A manufacturer shall maintain all records required under this part in a manner that ensures that both the manufacturer and the Food and Drug Administration can be provided with access to such records within 24 hours.                                                                                                                                                                                                                                                 |
| 1.0 year   | (n) Production control, product testing, testing results, complaints, and distribution records necessary to verify compliance with parts 106, 107, 109, 110, 113, and 117 of this chapter, or with other appropriate regulations, shall be retained for 1 year after the expiration of the shelf life of the infant formula or 3 years from the date of manufacture, whichever is greater.                                                                                   |
| 3.0 year   | (n) Production control, product testing, testing results, complaints, and distribution records necessary to verify compliance with parts 106, 107, 109, 110, 113, and 117 of this chapter, or with other appropriate regulations, shall be retained for 1 year after the expiration of the shelf life of the infant formula or 3 years from the date of manufacture, whichever is greater.                                                                                   |
| 90.0 day   | (a) At least 90 days before a new infant formula is introduced or delivered for introduction into interstate commerce, a manufacturer shall submit notice of its intent to do so to the Food and Drug Administration at the address given in &#167;&#8201;106.110(a).                                                                                                                                                                                                        |
| 90.0 day   | The manufacturer shall not market the new infant formula before the date that is 90 days after the filing date.                                                                                                                                                                                                                                                                                                                                                              |
| 24.0 month | (1) Birth to 24 months: Boys Head circumference-for-age and Weight-for-length percentiles, dated November 1, 2009, into &#167;&#8201;106.96(b)(4).                                                                                                                                                                                                                                                                                                                           |
| 24.0 month | (2) Birth to 24 months: Boys Length-for-age and Weight-for-age percentiles, dated November 1, 2009, into &#167;&#8201;106.96(b)(4).                                                                                                                                                                                                                                                                                                                                          |
| 24.0 month | (3) Birth to 24 months: Girls Head circumference-for-age and Weight-for-length percentiles, dated November 1, 2009, into &#167;&#8201;106.96(b)(4).                                                                                                                                                                                                                                                                                                                          |
| 24.0 month | (4) Birth to 24 months: Girls Length-for-age and Weight-for-age percentiles, dated November 1, 2009, into &#167;&#8201;106.96(b)(4).                                                                                                                                                                                                                                                                                                                                         |


## Condition

| Condition      | Context                                                                                                                           |
|:---------------|:----------------------------------------------------------------------------------------------------------------------------------|
| not subject to | which the infant formula is homogeneous and is not subject to  further degradation due to processing.                             |
| where          | formulation, or any change of ingredients or processes where experience or theory would predict a possible significant            |
| when           | of its nutrients, as prepared for market and when fed as the sole source of nutrition, to                                         |
| subject to     | packaged in a hermetically sealed container is also subject to the regulations in part 113 of this chapter,                       |
| subject to     | packaged in a hermetically sealed container is also subject to the regulations in part 113 of this chapter,                       |
| where          | point, step, or stage in the production process where control is necessary to prevent adulteration, a manufacturer                |
| when           | (3) Establish a corrective action plan for use when a specification established in accordance with paragraph (c)(1)               |
| when           | the work station, and at any other time when  the hands may become soiled or contaminated.                                        |
| until          | in-process materials, equipment, utensils, and infant formula product until the condition is corrected or determined by competent |
| where          | vapors (including steam and noxious fumes) in areas where they may contaminate the infant formula; and shall                      |
| when           | in the same condition that it will be when  it is used in infant formula manufacturing.                                           |
| where          | the toilet facility shall not open into areas where infant formula, ingredients, containers, or closures are processed,           |
| where          | the toilet facility shall not open into areas where infant formula, ingredients, containers, or closures are processed,           |
| if             | and which would render the infant formula adulterated if such substance were to come in contact with                              |
| where          | other parameter at any point, step, or stage where control is necessary to prevent adulteration of an                             |
| if             | instrument shows a failure to meet a spec if ication for a point where control is deemed                                          |
| where          | failure to meet a specification for a point where control is deemed necessary to prevent adulteration of                          |
| provided that  | (7.2 &#176;C) for a defined period of time provided that the manufacturer has scientific data and other information               |
| when           | not read lower than the reference temperature-indicating device. when                                                             |
| where          | the temperature in thermal processing equipment at points where  temperature control is necessary to prevent adulteration.        |
| where          | shall ensure, at any point, step, or stage where control is necessary to prevent adulteration of the                              |
| until          | its use in the manufacture of infant formula until an individual qualified by education, training, or experience                  |
| if             | or closure that complies with a manufacturer's spec if ications, or that has been released for use                                |
| if             | or closure that complies with a manufacturer's spec if ications, or that has been released for use                                |
| until          | its use in the manufacture of infant formula until an individual qualified by education, training, or experience                  |
| where          | that ensure that the equipment used at points where control is deemed necessary to prevent adulteration is                        |
| until          | prevent its use in manufacturing or processing operations until completion of the documented review and material disposition      |
| where          | or shipper, and the code established under &#167;&#8201;106.80. where                                                             |
| where          | satisfy the requirement of &#167;&#8201;107.20(c) of this chapter. where                                                          |
| provided that  | a unique identification number assigned by the packager, provided that the distributor of the package maintains a record          |
| until          | distribution of each production aggregate of infant formula until it determines that the production aggregate meets all           |
| until          | distribution of each production aggregate of infant formula until it determines that the production aggregate meets all           |
| until          | the manufacture of infant formula or its distribution until an individual qualified by education, training, or experience         |
| where          | number that identifies the product and the establishment where the product was packed and that permits tracing                    |
| if             | the requirements of paragraph (b)(1)(i) of this section if the manufacturer of a new infant formula requests                      |
| if             | this section do not substantiate the shelf l if e of the infant formula, the manufacturer shall                                   |
| if             | required or added nutrient; (ii) Evaluate the sign if icance,                                                                     |
| if             | required or added nutrient; (ii) Evaluate the sign if icance,                                                                     |
| where          | of the monitoring of points, steps, or stages where  control is deemed necessary to prevent adulteration; and                     |
| where          | from any specification at points, steps, or stages where control is deemed necessary to prevent adulteration were                 |
| when           | a formula supports normal physical growth in infants when fed as a sole source of nutrition by                                    |
| when           | the formula supports normal physical growth in infants when the formula is fed as the sole source                                 |
| when           | quality of the protein in the infant formula when fed as the sole source of nutrition using                                       |
| when           | infant formula supports normal physical growth in infants when the formula is fed as the sole source                              |
| when           | such formula supports normal physical growth in infants when fed as the sole source of nutrition and                              |
| subject to     | maintain all records that pertain to food-packaging materials subject to &#167;&#8201;174.5 of this chapter and that bear on      |
| when           | manufacturer by the premix supplier, including tests conducted when nutrients exceed their expiration date or shelf life          |
| when           | tests conducted to identify the nutrient levels present when nutrient premixes exceed their expiration date or shelf              |
| where          | points, steps, or stages in the production process where control is necessary to prevent adulteration; (iii) The                  |
| where          | or stage in the manufacturer 's production process where  control is deemed necessary to prevent adulteration.                    |
| where          | point, step, or stage in the production process where control is deemed necessary to prevent adulteration, in                     |
| where          | point, step, or stage in the production process where control is deemed necessary to prevent adulteration, in                     |
| where          | point, step, or stage in the production process where  control is deemed necessary to prevent adulteration.                       |
| if             | At a minimum, such records shall spec if y the instrument or control being checked, the                                           |
| where          | point, step, or stage in the production process where control is deemed necessary to prevent adulteration has                     |
| if             | the manufacturer of the ingredient, container, or closure, if  d                                                                  |
| when           | an investigation into the validity of the complaint. when                                                                         |
| when           | No investigation is necessary  when the manufacturer determines that there is no possibility                                      |
| when           | and notify the Agency as required in &#167;&#8201;106.150. when                                                                   |
| when           | file, they must be available within 24 hours when  requested by a Food and Drug Administration official.                          |
| where          | files regarding infant formula complaints at the establishment where  the infant formula was manufactured, processed, or packed.  |
| where          | at one location other than at the facility where an infant formula was manufactured, processed, or packed,                        |
| where          | available at any reasonable time at the establishment where  the activities described in such records occurred.                   |
| if             | as provided in paragraph (k)(6) of this section, if all required records are readily available at that                            |
| subject to     | These records or copies thereof shall be  subject to photocopying or other means of reproduction as part                          |
| unless         | of such notice of intent shall be submitted, unless the notice is submitted in conformance with part                              |
| when           | reconstituted with a specified volume of water, and, when applicable, a description of any reformulation of the                   |
| when           | (4) A description,  when applicable, of any change in processing of the                                                           |
| unless         | that the infant formula will not be marketed unless the formula meets the requirements for quality factors                        |
| unless         | statement that the formula will not be marketed unless it meets the nutrient requirements of &#167;&#8201;107.100 of              |
| if             | under &#167;&#8201;106.91(b)(1)(ii), the manufacturer shall include the scient if ic evidence that the manufacturer is relying on |
| unless         | of the Federal Food, Drug, and Cosmetic Act unless it complies fully with paragraph (b) of this                                   |
| if             | The Agency will not if y the manufacturer                                                                                         |
| if             | Drug Administration will acknowledge its receipt and not if y the manufacturer of the date of receipt.                            |
| if             | substantive amendment to the new infant formula submission. if                                                                    |
| when           | will acknowledge receipt of the additional information and, when applicable, notify the manufacturer of the new filing            |
| subject to     | (g) Submissions relating to exempt infant formulas are  subject to  the provisions of &#167;&#8201;107.50 of this chapter.        |
| unless         | study for each infant enrolled in the study. unless                                                                               |
| where          | beginning of the study and at every point where measurements were made throughout the study, and (ii)                             |
| if             | existing infant formula satisfies the criteria of &#167;&#8201;106.96(c)(1). if                                                   |
| if             | or study design is based on sound scient if ic principles, and data that demonstrate that the                                     |
| when           | the formula supports normal physical growth in infants when the formula is fed as the sole source                                 |
| if             | of the formula to support normal physical growth. if                                                                              |
| if             | potential for adversely affecting nutrient content and bioavailability. if                                                        |
| unless         | bioassay shall be provided in accordance with &#167;&#8201;106.96(f). unless                                                      |
| if             | infant formula satisfies the criteria listed in &#167;&#8201;106.96(g)(1). if                                                     |
| if             | does not affect the bioavailability of the protein. if                                                                            |
| if             | why the method is based on sound scient if ic principles, and the data that demonstrate that                                      |
| when           | Food, Drug, and Cosmetic Act (21 U.S.C. 350a(d)(2)) when any data prescribed in paragraph (b) of this                             |
| when           | Drug Administration at the address given in &#167;&#8201;106.110(a). when                                                         |
| unless         | of the Federal Food, Drug, and Cosmetic Act unless it complies fully with paragraph (b) of this                                   |
| if             | The Agency will not if y the manufacturer                                                                                         |
| when           | in accordance with paragraph (b) of this section when the manufacturer has knowledge (that is, actual knowledge                   |
| subject to     | the manufacturer and that has left an establishment subject to the control of the manufacturer: (1) May not                       |


## Entities

| Entities            | Context                                                                                                                                                         |
|:--------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Food                | Food  and Drugs.                                                                                                                                                |
| Failure             | Failure to comply with any regulation in subpart F                                                                                                              |
| Failure             | Failure to comply with any regulation in subpart G                                                                                                              |
| Eligible            | Eligible infant formula means an infant formula that could                                                                                                      |
| United States       | formula that could be lawfully distributed in the United States  on December 8, 2014.                                                                           |
| Indicator           | Indicator nutrient means a nutrient whose concentration is measured                                                                                             |
| Infant              | Infant means a person not more than 12 months                                                                                                                   |
| Infant              | Infant formula means a food which purports to be                                                                                                                |
| U.S                 | produced by a manufacturer who is entering the U.S . market; (2) Any infant formula powder processed                                                            |
| New                 | New infant formula means: (1) An infant formula manufactured                                                                                                    |
| U.S                 | Federal Food, Drug, and Cosmetic Act for the U.S . market.                                                                                                      |
| Nutrient            | Nutrient means any vitamin, mineral, or other substance or                                                                                                      |
| Medicine            | Food and Nutrition Board of the Institute of Medicine through its development of a Dietary Reference Intake,                                                    |
| Nutrient            | Nutrient premix means a combination of ingredients containing two                                                                                               |
| Quality             | Quality factors means those factors necessary to demonstrate the                                                                                                |
| Shall               | Shall  is used to state mandatory requirements.                                                                                                                 |
| Establish           | the article for use or distribution; and (5) Establish recordkeeping procedures, in accordance with &#167;&#8201;106.100(e)(3), that ensure                     |
| Good                | Good personal hygiene includes: (1) Wearing clean outer garments                                                                                                |
| Boiler              | Boiler water additives in the steam shall be used                                                                                                               |
| Such                | Such monitoring shall be at such frequency as is                                                                                                                |
| Agriculture         | Drug Administration or from the U.S. Department of Agriculture ; and (6) A substance that is not                                                                |
| Traceability        | Traceability .                                                                                                                                                  |
| E                   | aggregate shall be tested for vitamins A, C, E , and thiamin.                                                                                                   |
| Audit               | Audit  plans and procedures.                                                                                                                                    |
| Physical            | the data on the following charts from &#8220; Physical Growth: National Center for Health Statistics Percentiles&#8221; for                                     |
| Length              | Length by age percentiles for girls aged birth-36 months                                                                                                        |
| Length              | Length by age percentiles for boys aged birth-36 months                                                                                                         |
| Head                | Head circumference by age percentiles for girls aged birth-36                                                                                                   |
| Head                | Head circumference by age percentiles for boys aged birth-36                                                                                                    |
| Correspondence      | Correspondence about prices, package size or shape, or other                                                                                                    |
| New                 | New  infant formula registration.                                                                                                                               |
| Nutrition, Labeling | for Food Safety and Applied Nutrition, Office of Nutrition, Labeling , and Dietary Supplements, Infant Formula and Medical                                      |
| New                 | New  infant formula submission.                                                                                                                                 |
| Such                | Such description shall identify the specific change in processing,                                                                                              |
| Such                | Such assurance shall include: (i) A statement that the                                                                                                          |
| Such                | Such manufacturer shall also submit a statement certifying that                                                                                                 |
| Quality             | Quality  factor assurances for infant formulas.                                                                                                                 |
| Verification        | Verification  submission.                                                                                                                                       |
| Agency              | formula; and the identification number assigned by the Agency to the new infant formula submission: (2) A                                                       |
| Agency              | (b)(5), or (b)(6) has been provided to the Agency previously and has not been affected by the                                                                   |
| Enforcement         | and Applied Nutrition, Office of Compliance, Division of Enforcement (HFS-605), Recall Coordinator, 5001 Campus Dr., College Park,                              |
| Certain             | (a)  Certain material is incorporated by reference into this part                                                                                               |
| McLean, VA          | Sanitary Standards, Inc., 6888 Elm St., Suite 2D, McLean, VA 22101-3829, 703-790-0295, and may be ordered online at                                             |
| Bethesda, MD        | (c) American Society for Nutrition, 9650 Rockville Pike,  Bethesda, MD 20814-3998, 301-634-7279, http://www.nutrition.org: (1) Physical growth: National Center |
| Drizd, C.L          | Drizd, C.L .                                                                                                                                                    |
| Reed, A.F           | Reed, A.F .                                                                                                                                                     |
| Roche, and W.M      | Roche, and W.M .                                                                                                                                                |
| American Journal    | Moore,  American Journal  of Clinical Nutrition, vol.                                                                                                           |
| North               | (2) [Reserved]                                                                                                                                                  |
|                     |               (d) AOAC International, 481  North Frederick Ave., suite 500, Gaithersburg, MD 20877-2417, 301-924-7078:                                          |
| Atlanta, GA         | for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA  30333, 1-800-232-4636, http://www.cdc.gov/growthcharts/who_charts.htm.                       |


## Date

| Date       | Context                                                                                                                                                                                                                                                                                                    |
|:-----------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2014-12-08 | Eligible infant formula means an infant formula that could be lawfully distributed in the United States on December 8, 2014.                                                                                                                                                                               |
| 2013-04-08 | The Food and Drug Administration will determine compliance with the M values listed below using the latest edition of the Bacteriological Analytical Manual (BAM) (http://www.fda.gov/Food/FoodScienceResearch/LaboratoryMethods/BacteriologicalAnalyticalManualBAM/default.htm) (accessed April 8, 2013). |
| 2015-11-12 | (3) The manufacturer of an eligible infant formula may, not later than November 12, 2015, submit a petition to the Food and Drug Administration under &#167;&#8201;10.30 of this chapter that:                                                                                                             |
|            |               (i) Demonstrates that such formula fulfills one or more of the criteria in paragraph (i)(1) of this section; or                                                                                                                                                                              |
|            |               (ii) Demonstrates that such formula fulfills one or more of the criteria in paragraph (i)(2) of this section.                                                                                                                                                                                |
| 2004-11-21 | (1) 3-A Sanitary Standards, No. 609-03: A Method of Producing Culinary Steam, adopted November 21, 2004, into &#167;&#8201;106.20(h).                                                                                                                                                                      |
| 1979-03-01 | 607-614, dated March 1979, into &#167;&#8201;106.96(i)(1)(ii)(c).                                                                                                                                                                                                                                          |
| 2009-11-01 | (1) Birth to 24 months: Boys Head circumference-for-age and Weight-for-length percentiles, dated November 1, 2009, into &#167;&#8201;106.96(b)(4).                                                                                                                                                         |
| 2009-11-01 | (2) Birth to 24 months: Boys Length-for-age and Weight-for-age percentiles, dated November 1, 2009, into &#167;&#8201;106.96(b)(4).                                                                                                                                                                        |
| 2009-11-01 | (3) Birth to 24 months: Girls Head circumference-for-age and Weight-for-length percentiles, dated November 1, 2009, into &#167;&#8201;106.96(b)(4).                                                                                                                                                        |
| 2009-11-01 | (4) Birth to 24 months: Girls Length-for-age and Weight-for-age percentiles, dated November 1, 2009, into &#167;&#8201;106.96(b)(4).                                                                                                                                                                       |


